4D Molecular Therapeutics, Inc. ($FDMT)
Filing Information
| Accession Number | 0001193125-26-354313 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 17, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
9,810
Total Value
$53,104.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Aug 13, 2026 | Exercise/Conversion | 1,635 | $4.14 | $6,768.90 | 10,252 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Aug 13, 2026 | Sale | 1,635 | $12.00 | $19,620.00 | 8,617 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 1,635 | $4.14 | $6,768.90 | 10,252 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Aug 17, 2026 | Sale | 1,635 | $12.20 | $19,947.00 | 8,617 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Aug 13, 2026 | Exercise/Conversion | 1,635 | $0.00 | $0.00 | 61,336 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 1,635 | $0.00 | $0.00 | 59,701 | Direct | โ | View Details |